Skip to main content

LIVE

RYAM

Rayonier Advanced Materials Inc.

RYAM

NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $579.3M

$8.59

-0.12%

P/E

-4.13

Mkt Cap

$579.3M

52-Wk Range

$5.38–$11.85

52-Week Range

$5.38 - $11.85

P/E

-4.13

Fwd P/E

-7.41

Beta

1.77

Div Yield

0.00%

Avg Vol

985.4K

Shares Out

67.4M

Mkt Cap

$579.3M

Price action

Price chart

Up 52.9% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Vertically integrated production with established global supply chains across multiple continents
  • Diversified product portfolio serving resilient end-markets including personal care, pharmaceuticals, and industrial applications
  • Sustainable cellulose sourcing and production capabilities aligned with growing demand for eco-friendly materials
  • Nearly 100-year operational history providing manufacturing expertise and customer relationships

Bear Case

1 risk

  • Above-average volatility (beta 1.8).

Growth

Stable outlook

Rising demand for specialty cellulose in pharmaceutical and cosmetic formulations

Value

Deep value opportunity - significant discount to Commodity Chemicals peers

Momentum

Stable

-4.5% over 3m

Quality

Thin

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 3, 2026

Q3 26 RECAP

AUG 4, 2026

Reported EPS of -$0.30 vs -$0.22 consensus (-36.4% surprise). Revenue of $376.0M vs $362.0M expected (+3.9%).

EPS miss
Rev beat +3.9%

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-36.4%

Revenue trend · last 8Q

+0%

-8%

-19%

-12%

-1%

-10%

+11%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$401.1M

$422.5M

$356.0M

$340.0M

$353.0M

$417.0M

$319.1M

$376.0M

Margins · last 8Q

Gross

6.1%

Operating

-8.8%

Profit

-8.8%

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

Latest: RBC Capital · Mar 5, 2026

vs Industry

How RYAM stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.